{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:20:24Z","timestamp":1787804424679,"version":"build-2784847793"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020624","name":"NIHR Nottingham Biomedical Research Centre","doi-asserted-by":"crossref","award":["IS-BRC-1215-20003"],"award-info":[{"award-number":["IS-BRC-1215-20003"]}],"id":[{"id":"10.13039\/501100020624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"crossref","award":["MR\/Z505183\/1"],"award-info":[{"award-number":["MR\/Z505183\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"crossref"}]},{"award":["MR\/Z505183\/1"],"award-info":[{"award-number":["MR\/Z505183\/1"]}],"id":[{"id":"https:\/\/ror.org\/001aqnf71","id-type":"ROR","asserted-by":"publisher"}]},{"name":"NIHR Academic Clinical Fellowship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Sci.","Medical Sciences"],"abstract":"<jats:p>Blood transfusion near the end of life for patients with cancer may relieve symptoms attributed to anaemia or control bleeding, but its palliative value depends on whether benefit occurs within the patient\u2019s expected survival and outweighs the clinical and practical burden of treatment. This structured narrative review examines evidence concerning red-cell and platelet transfusion, transfusion-sparing patient blood management, hospice access and alternative delivery models in adults receiving palliative or end-of-life care. Structured searches of MEDLINE, Embase, Scopus and the Cochrane Library identified original studies, audits, qualitative research and relevant evidence syntheses. The evidence was predominantly observational and methodologically heterogeneous. Reported symptomatic response rates after red-cell transfusion ranged from 31% to 70%, most commonly involving short-term improvement in fatigue, dyspnoea or general well-being. Benefit often diminished within 14 days, while 23\u201335% of participants in historical cohorts died within two weeks, limiting the opportunity to experience benefit. Response was not reliably predicted by haemoglobin concentration. Red-cell transfusions were frequently guided by laboratory values, administered late in the disease course and not followed by systematic reassessment. Evidence concerning platelet transfusion remains largely descriptive and does not establish a prophylactic threshold for end-of-life care. Intravenous iron and haemostatic radiotherapy may reduce transfusion requirements in selected patients, although their applicability depends on clinical stability, the source of bleeding and sufficient time to benefit. In haematological malignancies, transfusion dependence has been associated with lower hospice enrolment and shorter hospice stays, whereas home- and hospice-based transfusion may reduce travel and waiting burdens for appropriately selected patients. Transfusion near the end of life should therefore be considered a goal-concordant, time-limited trial. A patient-valued outcome should be defined beforehand, the fewest units likely to achieve that outcome should be administered, and benefit should be reassessed using the same measure. Further transfusion should be offered only when documented symptomatic or functional benefit outweighs adverse effects and treatment burden for the individual patient.<\/jats:p>","DOI":"10.3390\/medsci14050512","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:00:48Z","timestamp":1787644848000},"page":"512","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood Transfusion in End-of-Life Cancer Care: Clinical Evidence, Patient Blood Management and Goal-Concordant Practice"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-5295","authenticated-orcid":false,"given":"Saikat","family":"Mandal","sequence":"first","affiliation":[{"name":"Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK"},{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-5158","authenticated-orcid":false,"given":"Manideepa","family":"Maji","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of Hull, Hull HU6 7RX, UK"},{"name":"Haematology, Hull University Teaching Hospitals NHS Trust, Hull HU16 5JQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sharma","sequence":"additional","affiliation":[{"name":"Medical Oncology, Smilow Cancer Hospital, Yale New Haven Hospital, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-2569","authenticated-orcid":false,"given":"Arkadeep","family":"Dhali","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Trust, Sheffield S5 7AU, UK"},{"name":"Division of Surgery and Cancer, Imperial College London, London W12 0NN, UK"},{"name":"School of Medicine, Dentistry and Biomedical Sciences, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2013.02.021","article-title":"Concepts and definitions for \u201cactively dying,\u201d \u201cend of life,\u201d \u201cterminally ill,\u201d \u201cterminal care,\u201d and \u201ctransition of care\u201d: A systematic review","volume":"47","author":"Hui","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100225","DOI":"10.1016\/j.esmoop.2021.100225","article-title":"Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines","volume":"6","author":"Crawford","year":"2021","journal-title":"ESMO Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/JCO.18.02386","article-title":"Palliative and End-of-Life Care for Patients With Hematologic Malignancies","volume":"38","author":"Nelson","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/trf.14413","article-title":"Red blood cell transfusion in adult palliative care: A systematic review","volume":"58","author":"Taylor","year":"2018","journal-title":"Transfusion"},{"key":"ref_5","first-page":"CD009007","article-title":"Blood transfusions for anaemia in patients with advanced cancer","volume":"2012","author":"Preston","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/026921639500900405","article-title":"Blood transfusion and its benefits in palliative care","volume":"9","author":"Gleeson","year":"1995","journal-title":"Palliat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0885-3924(96)00044-9","article-title":"Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit","volume":"12","author":"Monti","year":"1996","journal-title":"J. Pain Symptom Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/0269216308094521","article-title":"Letter to editor: An observational study of red cell transfusion in specialist palliative care","volume":"22","author":"Laird","year":"2008","journal-title":"Palliat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1089\/jpm.2017.0072","article-title":"The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care","volume":"20","author":"To","year":"2017","journal-title":"J. Palliat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0269216318801755","article-title":"National comparative audit of red blood cell transfusion practice in hospices: Recommendations for palliative care practice","volume":"33","author":"Neoh","year":"2019","journal-title":"Palliat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.25259\/IJPC_356_2024","article-title":"Blood Transfusions in Patients with Advanced Cancer at the End-of-Life: Are They Really Beneficial?","volume":"31","author":"Callaghan","year":"2025","journal-title":"Indian J. Palliat. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/jpm.2006.0199","article-title":"Survey of blood transfusion practice for palliative care patients in Yorkshire: Implications for clinical care","volume":"10","author":"Brown","year":"2007","journal-title":"J. Palliat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1089\/jpm.2010.0143","article-title":"Assessment of fatigue after blood transfusion in palliative care patients: A feasibility study","volume":"13","author":"Brown","year":"2010","journal-title":"J. Palliat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/jpm.2018.0605","article-title":"Red Blood Cell Transfusion in Palliative Care: A Survey of Palliative Care Physicians","volume":"22","author":"Taylor","year":"2019","journal-title":"J. Palliat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/vox.12986","article-title":"Platelet transfusions in haematologic malignancies in the last six months of life","volume":"116","author":"Moracchini","year":"2021","journal-title":"Vox Sang."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/cncr.29913","article-title":"Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database","volume":"122","author":"Fletcher","year":"2016","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2018-03-842575","article-title":"Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia","volume":"132","author":"LeBlanc","year":"2018","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2541719","DOI":"10.1001\/jamanetworkopen.2025.41719","article-title":"Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers","volume":"8","author":"Raman","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpainsymman.2023.09.024","article-title":"Perspectives on Transfusions for Hospice Patients With Blood Cancers: A Survey of Hospice Providers","volume":"67","author":"Knight","year":"2024","journal-title":"J. Pain Symptom Manag."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_21","first-page":"199","article-title":"The use of blood transfusions and erythropoietin-stimulating agents in Swedish palliative care","volume":"17","author":"Martinsson","year":"2009","journal-title":"Support. Care Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09699260.2017.1328774","article-title":"Do blood transfusions make a difference when you are dying?","volume":"25","author":"Woodwark","year":"2017","journal-title":"Prog. Palliat. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1049909118806456","article-title":"A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting","volume":"36","author":"Sirianni","year":"2019","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Timilsina, S., Karki, S., Timalsina, S., Gautam, A., and Sharma, S. (2019). Does packed red cell transfusion provide symptomatic benefits to cancer palliative patients?: A longitudinal study from a single private oncology center in Nepal. BMC Palliat. Care, 18.","DOI":"10.1186\/s12904-019-0454-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/j.pbj.0000000000000195","article-title":"Transfusion practices in patients with advanced cancer: A retrospective study in a palliative care service","volume":"7","author":"Marote","year":"2022","journal-title":"Porto Biomed. J."},{"key":"ref_26","first-page":"e285","article-title":"Red cell transfusions in patients with cancer in palliative care: A multicentric study","volume":"10","author":"Sousa","year":"2025","journal-title":"Porto Biomed. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/jpm.2024.0153","article-title":"Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care","volume":"27","author":"Ostan","year":"2024","journal-title":"J. Palliat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.7314\/APJCP.2014.15.10.4251","article-title":"Use of blood transfusion at the end of life: Does it have any effects on survival of cancer patients?","volume":"15","author":"Goksu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/trf.16560","article-title":"Red blood cell transfusion and associated outcomes in patients referred for palliative care: A retrospective cohort study","volume":"61","author":"Scott","year":"2021","journal-title":"Transfusion"},{"key":"ref_30","first-page":"319","article-title":"End-of-life transfusions in patients with an oncological diagnosis","volume":"28","author":"Estrada","year":"2021","journal-title":"Rev. Soc. Esp. Dolor"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bulcan.2020.08.007","article-title":"\u00c9tude des repr\u00e9sentations de la transfusion plaquettaire en fin de vie par ses acteurs: Patients, infirmiers et m\u00e9decins d\u2019h\u00e9matologie [Study of representations of end-of-life platelet transfusion by its protagonists: Patients, nurses and hematologic oncologists]","volume":"107","author":"Moracchini","year":"2020","journal-title":"Bull. Cancer"},{"key":"ref_32","first-page":"1927","article-title":"Transfusion practices at end of life for hematopoietic stem cell transplant patients","volume":"26","author":"Wang","year":"2018","journal-title":"Support. Care Cancer"},{"key":"ref_33","first-page":"656","article-title":"Differences in perceptions of hematologists and palliative care physicians regarding transfusion therapy in patients with terminal hematological malignancies: A nationwide cross-sectional questionnaire survey in Japan","volume":"34","author":"Hattori","year":"2026","journal-title":"Support. Care Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2708","DOI":"10.1136\/spcare-2023-004218","article-title":"End of life in haematology: Quality of life predictors\u2014Retrospective cohort study","volume":"14","author":"Korsos","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ejh.13843","article-title":"Palliative care utilization, transfusion burden, and end-of-life care for patients with multiple myeloma","volume":"109","author":"McInturf","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/10499091211013290","article-title":"Bereaved Informal Caregivers Rarely Recall a Relationship Between Transfusions and Hospice in Acute Myeloid Leukemia","volume":"39","author":"Cripe","year":"2022","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/02692163211000634","article-title":"Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy","volume":"35","author":"Shaulov","year":"2021","journal-title":"Palliat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/02692163221145604","article-title":"The ICaRAS randomised controlled trial: Intravenous iron to treat anaemia in people with advanced cancer\u2014Feasibility of recruitment, intervention and delivery","volume":"37","author":"Dickson","year":"2023","journal-title":"Palliat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/10499091251335266","article-title":"Intravenous Iron as an Alternative to Blood Transfusion in Cancer Patients: A Single Center Experience","volume":"43","author":"Yeung","year":"2026","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1080\/01635581.2018.1504090","article-title":"Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma","volume":"70","author":"Ng","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10120-021-01254-w","article-title":"Treatment response after palliative radiotherapy for bleeding gastric cancer: A multicenter prospective observational study (JROSG 17-3)","volume":"25","author":"Saito","year":"2022","journal-title":"Gastric Cancer"},{"key":"ref_42","first-page":"355","article-title":"Hemostatic Effect of Palliative Radiation Therapy in Preventing Blood Transfusions from Bleeding Occurring within Advanced Gastric Cancer","volume":"2","author":"Mitsuhashi","year":"2021","journal-title":"Palliat. Med. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4103\/jcrt.jcrt_2090_21","article-title":"Usefulness of palliative radiotherapy in reducing the frequency of red blood cell transfusion in patients with malignant tumor bleeding","volume":"19","author":"Katano","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/jpm.2022.0249","article-title":"Effect of Anticoagulant\/Antifibrinolytic Combination Therapy on Enhanced Fibrinolytic-Type Disseminated Intravascular Coagulation in End-of-Life Stage Solid Tumor Patients","volume":"26","author":"Yamada","year":"2023","journal-title":"J. Palliat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-026-06789-5","article-title":"Comparison of safety and efficacy of liberal versus restrictive red blood cell transfusion thresholds on the quality of life in patients with myelodysplastic syndromes: A systematic review and meta-analysis","volume":"105","author":"Mandal","year":"2026","journal-title":"Ann. Hematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/vox.70241","article-title":"Parenteral iron-Does it increase infection risk?","volume":"121","author":"Deb","year":"2026","journal-title":"Vox Sang."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mandal, S., Taylor, M., Mohan, A.K., Hasan, S.R., Maji, M., Aydin, M.M., Sil, S., and Dhali, A. (2026). Does Parenteral Iron Increase the Risk of Infection in Patients with Gastrointestinal Cancer? A Systematic Review and Meta-Analysis. Cancers, 18.","DOI":"10.3390\/cancers18121859"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/CCO.0000000000001024","article-title":"A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: A double-edged sword?","volume":"36","author":"Meyers","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bjh.18344","article-title":"Home-based blood transfusion therapy: A systematic review","volume":"199","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpainsymman.2025.09.021","article-title":"Effectiveness and Safety of Home-Based RBC Transfusions in Advanced Hematologic and Solid Tumors","volume":"71","author":"Miyashita","year":"2026","journal-title":"J. Pain Symptom Manag."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/trf.14816","article-title":"Home transfusion: Three decades of practice at a tertiary care hospital","volume":"58","author":"Aguilera","year":"2018","journal-title":"Transfusion"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/trf.17728","article-title":"Patient and caregiver perceptions of the possibility of home blood transfusions","volume":"64","author":"Binder","year":"2024","journal-title":"Transfusion"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.12968\/ijpn.2013.19.4.171","article-title":"The experiences of patients undergoing blood transfusion in a day hospice","volume":"19","author":"Orme","year":"2013","journal-title":"Int. J. Palliat. Nurs."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10198-011-0328-9","article-title":"Cancer patients\u2019 willingness to pay for blood transfusions at home: Results from a contingent valuation study in a French cancer network","volume":"13","author":"Havet","year":"2012","journal-title":"Eur. J. Health Econ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tracli.2010.09.165","article-title":"Transfusion en hospitalisation \u00e0 domicile [Home blood transfusion]","volume":"17","author":"Gay","year":"2010","journal-title":"Transfus. Clin. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"h5832","DOI":"10.1136\/bmj.h5832","article-title":"Blood transfusion: Summary of NICE guidance","volume":"351","author":"Padhi","year":"2015","journal-title":"BMJ"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/vox.13442","article-title":"Patient blood management: Myths and facts about red blood cell transfusions","volume":"118","author":"Gammon","year":"2023","journal-title":"Vox Sang."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/aob-24-28","article-title":"End-of-life blood transfusion can improve quality of life-a narrative review of debate on scope and consideration","volume":"10","author":"Sil","year":"2025","journal-title":"Ann. Blood"},{"key":"ref_59","unstructured":"American Society of Hematology (2019). ASH Statement in Support of Palliative Blood Transfusions in Hospice Setting, American Society of Hematology."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Taylor, A.O., Reyes-Rodriguez, A.Q., and LeBlanc, T.W. (2026). Clinical, Ethical, and Financial Considerations With Red Blood Cell Transfusion Support at the End of Life in Hematologic Malignancies. Am. J. Hosp. Palliat. Care, 10499091261462789.","DOI":"10.1177\/10499091261462789"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/hematology.2024000560","article-title":"Challenges in hospice and end-of-life care in the transfusion-dependent patient","volume":"2024","author":"Rodenbach","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/512\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:16:04Z","timestamp":1787804164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medsci14050512"],"URL":"https:\/\/doi.org\/10.3390\/medsci14050512","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}